MX361136B - Compuestos quimicos. - Google Patents
Compuestos quimicos.Info
- Publication number
- MX361136B MX361136B MX2015009465A MX2015009465A MX361136B MX 361136 B MX361136 B MX 361136B MX 2015009465 A MX2015009465 A MX 2015009465A MX 2015009465 A MX2015009465 A MX 2015009465A MX 361136 B MX361136 B MX 361136B
- Authority
- MX
- Mexico
- Prior art keywords
- chemical compounds
- formula
- pharmaceutically
- processes
- preparation
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4965—Non-condensed pyrazines
- A61K31/497—Non-condensed pyrazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
Abstract
La invención se relaciona con compuestos de Fórmula (I), o sales farmacéuticamente aceptables de los mismos, en donde R1 y R2 tienen cualquiera de los significados definidos anteriormente en la presente en la descripción; procesos para su preparación, composiciones farmacéuticas que los contienen y su uso en el tratamiento de trastornos proliferativos celulares. (ver Fórmula).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13305078 | 2013-01-23 | ||
PCT/GB2014/050163 WO2014114928A1 (en) | 2013-01-23 | 2014-01-22 | Chemical compounds |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2015009465A MX2015009465A (es) | 2015-09-28 |
MX361136B true MX361136B (es) | 2018-11-28 |
Family
ID=47623992
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2015009465A MX361136B (es) | 2013-01-23 | 2014-01-22 | Compuestos quimicos. |
Country Status (27)
Country | Link |
---|---|
US (2) | US9156831B2 (es) |
EP (1) | EP2948447B1 (es) |
JP (1) | JP6307096B2 (es) |
KR (1) | KR102202516B1 (es) |
CN (1) | CN104936953B (es) |
AP (1) | AP2015008604A0 (es) |
AR (1) | AR094553A1 (es) |
AU (1) | AU2014208964B2 (es) |
BR (1) | BR112015017331B1 (es) |
CA (1) | CA2897279C (es) |
CL (1) | CL2015002027A1 (es) |
CR (1) | CR20150367A (es) |
DO (1) | DOP2015000170A (es) |
ES (1) | ES2608395T3 (es) |
HK (1) | HK1214592A1 (es) |
IL (1) | IL239890A0 (es) |
MA (1) | MA38287B1 (es) |
MX (1) | MX361136B (es) |
NI (1) | NI201500096A (es) |
PE (1) | PE20151979A1 (es) |
PH (1) | PH12015501584A1 (es) |
RU (1) | RU2644769C2 (es) |
SG (1) | SG11201505631PA (es) |
TN (1) | TN2015000313A1 (es) |
TW (1) | TWI606047B (es) |
UY (1) | UY35275A (es) |
WO (1) | WO2014114928A1 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2016146591A1 (en) * | 2015-03-16 | 2016-09-22 | Astrazeneca Ab | Combination treatment |
TW201726140A (zh) | 2015-09-17 | 2017-08-01 | 瑞典商阿斯特捷利康公司 | 治療癌症之新型生物標記及方法 |
TW201825465A (zh) | 2016-09-23 | 2018-07-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201813963A (zh) | 2016-09-23 | 2018-04-16 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
TW201815787A (zh) | 2016-09-23 | 2018-05-01 | 美商基利科學股份有限公司 | 磷脂醯肌醇3-激酶抑制劑 |
CN107137405A (zh) * | 2017-04-14 | 2017-09-08 | 黄德莲 | 一种治疗肾炎的药物组合物 |
CN110317190A (zh) * | 2018-03-28 | 2019-10-11 | 首都医科大学 | 一种三唑-羧酸酯类衍生物在医药领域的应用 |
US20220033775A1 (en) | 2018-11-05 | 2022-02-03 | Iovance Biotherapeutics, Inc. | Expansion of tils utilizing akt pathways inhibitors |
WO2020094363A1 (en) | 2018-11-05 | 2020-05-14 | Syngenta Participations Ag | Pesticidally active azole-amide compounds |
US20220167618A1 (en) | 2019-03-08 | 2022-06-02 | Syngenta Crop Protection Ag | Pesticidally active azole-amide compounds |
WO2020188014A1 (en) | 2019-03-20 | 2020-09-24 | Syngenta Crop Protection Ag | Pesticidally active azole amide compounds |
WO2020193341A1 (en) | 2019-03-22 | 2020-10-01 | Syngenta Crop Protection Ag | N-[1-(5-bromo-2-pyrimidin-2-yl-1,2,4-triazol-3-yl)ethyl]-2-cyclopropyl-6-(trifluoromethyl)pyridine-4-carboxamide derivatives and related compounds as insecticides |
CN115443128A (zh) | 2020-04-24 | 2022-12-06 | 阿斯利康(瑞典)有限公司 | 药物配制品 |
Family Cites Families (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL7112373A (es) | 1970-09-25 | 1972-03-28 | ||
US4256887A (en) | 1978-04-06 | 1981-03-17 | Merck & Co., Inc. | 1,2,4-Triazoles and a method for their preparation |
US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
JP3028168B2 (ja) | 1993-03-29 | 2000-04-04 | 住化ファインケム株式会社 | ベンゼンスルホンアミド誘導体の製造方法 |
US5656416A (en) | 1994-12-22 | 1997-08-12 | Eastman Kodak Company | Photographic processing composition and method using organic catalyst for peroxide bleaching agent |
CA2212061A1 (en) | 1995-02-02 | 1996-08-08 | Laramie Mary Gaster | Indole derivatives as 5-ht receptor antagonist |
GB9517559D0 (en) | 1995-08-26 | 1995-10-25 | Smithkline Beecham Plc | Novel compounds |
ZA9610738B (en) | 1995-12-22 | 1997-06-24 | Warner Lambert Co | Subtype selective nmda receptor ligands and the use thereof |
CA2260900A1 (en) | 1996-07-25 | 1998-02-05 | Merck Sharp & Dohme Limited | Substituted triazolo pyridazine derivatives as inverse agonists of the gabaa.alpha.5 receptor subtype |
GB9711753D0 (en) | 1997-06-06 | 1997-08-06 | Merck Sharp & Dohme | Therapeutic agents |
WO2002006271A1 (en) | 2000-07-19 | 2002-01-24 | F. Hoffmann-La Roche Ag | Pyrimidine derivatives |
BR0214309A (pt) | 2001-11-21 | 2004-10-13 | Upjohn Co | Derivados aril-1,4-pirazina substituìdos |
US7012077B2 (en) | 2001-12-20 | 2006-03-14 | Hoffmann-La Roche Inc. | Substituted cyclohexane derivatives |
WO2003062224A1 (en) | 2002-01-17 | 2003-07-31 | Eli Lilly And Company | Aza-cyclic compounds as modulators of acetylcholine receptors |
US20030195192A1 (en) | 2002-04-05 | 2003-10-16 | Fortuna Haviv | Nicotinamides having antiangiogenic activity |
EP1501514B1 (en) | 2002-05-03 | 2012-12-19 | Exelixis, Inc. | Protein kinase modulators and methods of use |
GB0306097D0 (en) | 2003-03-15 | 2003-04-23 | Elam T Ltd | Electroluminescent complexes |
EP1606266A4 (en) | 2003-03-21 | 2008-06-25 | Smithkline Beecham Corp | CHEMICAL COMPOUNDS |
DE10348044A1 (de) | 2003-10-15 | 2005-05-19 | Imtm Gmbh | Duale Alanyl-Aminopeptidase- und Dipeptidylpeptidase IV-Inhibitoren zur funktionellen Beeinflussung unterschiedlicher Zellen und zur Behandlung immunologischer, entzündlicher, neuronaler und anderer Erkrankungen |
EP1704145B1 (en) | 2004-01-12 | 2012-06-13 | YM BioSciences Australia Pty Ltd | Selective kinase inhibitors |
AU2005252160A1 (en) | 2004-04-13 | 2005-12-22 | Astellas Pharma Inc. | Polycyclic pyrazines as potassium ion channel modulators |
JP2006028056A (ja) | 2004-07-14 | 2006-02-02 | Agro Kanesho Co Ltd | ピリミジン誘導体及びこれを含む有害生物防除剤 |
CA2575081C (en) | 2004-07-26 | 2013-05-07 | Eli Lilly And Company | Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
MX2007003321A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como agentes terapeuticos. |
TW200626592A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
CN101242834A (zh) | 2004-12-15 | 2008-08-13 | 默克公司 | Akt活性抑制剂 |
WO2006084030A2 (en) | 2005-02-01 | 2006-08-10 | Sloan-Kettering Institute For Cancer Research | Small-molecule hsp90 inhibitors |
RU2421454C2 (ru) | 2005-06-10 | 2011-06-20 | Мерк Шарп Энд Домэ Корп. | Ингибиторы активности акт |
WO2007096764A2 (en) | 2006-02-27 | 2007-08-30 | Glenmark Pharmaceuticals S.A. | Bicyclic heteroaryl derivatives as cannabinoid receptor modulators |
WO2007111904A2 (en) | 2006-03-22 | 2007-10-04 | Vertex Pharmaceuticals Incorporated | C-met protein kinase inhibitors for the treatment of proliferative disorders |
TW200808800A (en) | 2006-05-05 | 2008-02-16 | Astrazeneca Ab | MGluR5 modulators V |
CN101472912A (zh) | 2006-06-22 | 2009-07-01 | 比奥维特罗姆上市公司 | 作为mnk激酶抑制剂的吡啶和吡嗪衍生物 |
AU2007269144B2 (en) | 2006-06-30 | 2013-05-16 | Sloan-Kettering Institute For Cancer Research | Treatment of neurodegenerative diseases through inhibition of HSP90 |
TW200817375A (en) | 2006-07-21 | 2008-04-16 | Irm Llc | Compounds and compositions as ITPKB inhibitors |
PL2057156T3 (pl) | 2006-08-23 | 2017-08-31 | Kudos Pharmaceuticals Limited | Pochodne 2-metylomorfolinowe pirydo-, pirazo- i pirymido-pirymidyny jako inhibitory mTOR |
JP5206993B2 (ja) | 2007-03-07 | 2013-06-12 | 日産化学工業株式会社 | イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤 |
TWI439272B (zh) | 2007-08-14 | 2014-06-01 | 拜耳知識產權公司 | 稠合雙環嘧啶 |
WO2009024825A1 (en) | 2007-08-21 | 2009-02-26 | Astrazeneca Ab | 2-pyrazinylbenzimidazole derivatives as receptor tyrosine kinase inhibitors |
KR101494734B1 (ko) | 2007-10-11 | 2015-02-26 | 아스트라제네카 아베 | 단백질 키나제 b 억제제로서 피롤로[2,3-d]피리미딘 유도체 |
CA2703653A1 (en) | 2007-10-25 | 2009-04-30 | Astrazeneca Ab | Pyridine and pyrazine derivatives -083 |
JPWO2009072621A1 (ja) | 2007-12-07 | 2011-04-28 | 日産化学工業株式会社 | 置換ジヒドロアゾール化合物及び有害生物防除剤 |
US20100298286A1 (en) | 2007-12-20 | 2010-11-25 | Novartis Ag | Organic Compounds |
CA2709918A1 (en) | 2007-12-21 | 2009-06-25 | The Scripps Research Institute | Benzopyrans and analogs as rho kinase inhibitors |
US20110105500A1 (en) | 2008-06-27 | 2011-05-05 | S*Bio Pte Ltd. | Pyrazine substituted purines |
AU2009289316A1 (en) | 2008-09-02 | 2010-03-11 | Novartis Ag | Bicyclic kinase inhibitors |
JP2010083883A (ja) | 2008-09-08 | 2010-04-15 | Nissan Chem Ind Ltd | イソキサゾリン置換ベンズアミド化合物及び有害生物防除剤 |
UA104147C2 (uk) * | 2008-09-10 | 2014-01-10 | Новартис Аг | Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань |
JP2010063863A (ja) | 2008-09-11 | 2010-03-25 | Mugen:Kk | ヘッドのフェース部背面に音響振動の異なるパイプまたは平板を複数設けた打点位置表示型ゴルフ練習用クラブとその製法 |
CN101676271B (zh) | 2008-09-17 | 2011-12-14 | 山东轩竹医药科技有限公司 | 含有不饱和杂环胺的四环素衍生物 |
EP2370424A1 (en) | 2008-11-10 | 2011-10-05 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of atr kinase |
PT2356113E (pt) * | 2008-11-14 | 2015-04-14 | Bayer Ip Gmbh | Compostos arilo substituídos heterociclicamente como inibidores de hif |
RU2604066C2 (ru) | 2008-12-19 | 2016-12-10 | Вертекс Фармасьютикалз Инкорпорейтед | Производные пиразина, используемые в качестве ингибиторов киназы atr |
CA2740193A1 (en) | 2008-12-23 | 2010-07-01 | Abbott Laboratories | Anti-viral compounds |
WO2010086613A1 (en) | 2009-01-30 | 2010-08-05 | Betagenon Ab | Compounds useful as inhibitors as ampk |
CA2752114C (en) * | 2009-02-13 | 2017-06-20 | Bayer Pharma Aktiengesellschaft | Fused pyrimidines as akt inhibitors |
MX2011008583A (es) | 2009-02-13 | 2011-12-12 | Bayer Pharma AG | Pirimidinas fusionadas. |
JP2012520868A (ja) | 2009-03-20 | 2012-09-10 | ファイザー・インク | 3−オキサ−7−アザビシクロ[3.3.1]ノナン |
GB0909441D0 (en) | 2009-06-02 | 2009-07-15 | Univ Sheffield | Novel indole derivatives |
US8293753B2 (en) | 2009-07-02 | 2012-10-23 | Novartis Ag | Substituted 2-carboxamide cycloamino ureas |
WO2011025690A1 (en) | 2009-08-27 | 2011-03-03 | Merck Sharp & Dohme Corp. | Novel pyrrolidine derived beta 3 adrenergic receptor agonists |
TW201125867A (en) | 2009-10-20 | 2011-08-01 | Cellzome Ltd | Heterocyclyl pyrazolopyrimidine analogues as JAK inhibitors |
US8399460B2 (en) | 2009-10-27 | 2013-03-19 | Astrazeneca Ab | Chromenone derivatives |
EP2338888A1 (en) | 2009-12-24 | 2011-06-29 | Almirall, S.A. | Imidazopyridine derivatives as JAK inhibitors |
ES2627703T3 (es) | 2010-01-22 | 2017-07-31 | Fundación Centro Nacional De Investigaciones Oncológicas Carlos Iii | Inhibidores de PI3·quinasa |
CA2789021C (en) | 2010-02-05 | 2018-02-06 | Merck Patent Gmbh | Hetaryl-[1,8]naphthyridine derivatives |
JP2011178673A (ja) | 2010-02-26 | 2011-09-15 | Nissan Chem Ind Ltd | 非農園芸害虫の防除方法 |
SG10201502484SA (en) | 2010-03-30 | 2015-05-28 | Verseon Corp | Multisubstituted aromatic compounds as inhibitors of thrombin |
US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
US9630956B2 (en) | 2010-05-12 | 2017-04-25 | Vertex Pharmaceuticals Incorporated | Compounds useful as inhibitors of ATR kinase |
CN102311396B (zh) | 2010-07-05 | 2015-01-07 | 暨南大学 | 一种吡嗪类衍生物和其制备方法及在制药中的应用 |
ES2612503T3 (es) | 2010-09-14 | 2017-05-17 | Exelixis, Inc. | Compuestos 9H-purina como inhibidores de PI3K-delta y métodos para su preparación |
US9181264B2 (en) * | 2010-09-16 | 2015-11-10 | Hutchison Medipharma Limited | Fused heteroaryls and their uses |
WO2012068589A2 (en) | 2010-11-19 | 2012-05-24 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
CN102718745A (zh) * | 2011-03-30 | 2012-10-10 | 中国科学院上海药物研究所 | 新型胺基吡啶类化合物、其制备方法、包含此类化合物的药物组合物及其用途 |
AU2012258618B2 (en) | 2011-05-26 | 2017-05-25 | Sunovion Pharmaceuticals Inc. | Metabotropic glutamate receptors 5 modulators and methods of use thereof |
WO2013049591A2 (en) | 2011-09-29 | 2013-04-04 | Verseon Corporation | Dual inhibitor compounds and methods of use thereof |
RS56673B1 (sr) | 2012-04-05 | 2018-03-30 | Vertex Pharma | Jedinjenja korisna kao inhibitori atr kinaze i kombinovane terapije koje ih koriste |
-
2014
- 2014-01-22 JP JP2015554244A patent/JP6307096B2/ja active Active
- 2014-01-22 MX MX2015009465A patent/MX361136B/es active IP Right Grant
- 2014-01-22 KR KR1020157021103A patent/KR102202516B1/ko active IP Right Grant
- 2014-01-22 AR ARP140100196A patent/AR094553A1/es unknown
- 2014-01-22 PE PE2015001341A patent/PE20151979A1/es not_active Application Discontinuation
- 2014-01-22 MA MA38287A patent/MA38287B1/fr unknown
- 2014-01-22 CA CA2897279A patent/CA2897279C/en active Active
- 2014-01-22 US US14/160,650 patent/US9156831B2/en active Active
- 2014-01-22 RU RU2015132370A patent/RU2644769C2/ru active
- 2014-01-22 AU AU2014208964A patent/AU2014208964B2/en active Active
- 2014-01-22 CN CN201480005179.8A patent/CN104936953B/zh active Active
- 2014-01-22 WO PCT/GB2014/050163 patent/WO2014114928A1/en active Application Filing
- 2014-01-22 BR BR112015017331-4A patent/BR112015017331B1/pt active IP Right Grant
- 2014-01-22 SG SG11201505631PA patent/SG11201505631PA/en unknown
- 2014-01-22 EP EP14701828.7A patent/EP2948447B1/en active Active
- 2014-01-22 ES ES14701828.7T patent/ES2608395T3/es active Active
- 2014-01-22 AP AP2015008604A patent/AP2015008604A0/xx unknown
- 2014-01-23 UY UY0001035275A patent/UY35275A/es not_active Application Discontinuation
- 2014-01-23 TW TW103102536A patent/TWI606047B/zh active
-
2015
- 2015-07-09 IL IL239890A patent/IL239890A0/en unknown
- 2015-07-10 CR CR20150367A patent/CR20150367A/es unknown
- 2015-07-16 PH PH12015501584A patent/PH12015501584A1/en unknown
- 2015-07-16 DO DO2015000170A patent/DOP2015000170A/es unknown
- 2015-07-21 CL CL2015002027A patent/CL2015002027A1/es unknown
- 2015-07-22 TN TN2015000313A patent/TN2015000313A1/en unknown
- 2015-07-22 NI NI201500096A patent/NI201500096A/es unknown
- 2015-08-31 US US14/840,209 patent/US9657008B2/en active Active
-
2016
- 2016-03-04 HK HK16102484.1A patent/HK1214592A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12015502615A1 (en) | Chemical compounds | |
TN2015000313A1 (en) | Chemical compounds | |
PH12018500987A1 (en) | Dihydroimidazopyrazinone derivatives useful in the treatment of cancer | |
PH12018502535A1 (en) | Substituted carbonucleoside derivatives useful as anticancer agents | |
MD20170070A2 (ro) | Derivaţi de chinazolină utilizaţi în tratamentul HIV | |
MX2017008520A (es) | Compuestos de pirimidina fusionada para el tratamiento del virus de inmunodeficiencia humana (vih). | |
CL2015001985A1 (es) | Compuestos de tiazolcarboxamidas y piridinacarboxamida, inhibidores de quinasa pim. | |
PH12015501150B1 (en) | Compounds and their methods of use | |
MX2017008518A (es) | Compuestos de isoquinolina para el tratamiento de virus de inmunodeficiencia humana (vih). | |
EA201491505A1 (ru) | Соединения для лечения спинальной мышечной атрофии | |
PH12015501609A1 (en) | Phenicol antibacterials | |
PH12018500446A1 (en) | Pyridinone dicarboxamide for use as bromodomain inhibitors | |
TW201613864A (en) | Novel compounds | |
PH12016500347A1 (en) | Triazolopyridine compounds, compositions and methods of use thereof | |
PH12017500159A1 (en) | [1,2,4]triazolo[4,3-b]pyridazines for use in the treatment of proliferative diseases | |
IN2015DN02109A (es) | ||
MX360040B (es) | Nuevo agente antibacteriano derivado de florfenicol unido a sulfoximina y el uso del mismo en el tratamiento de infecciones bacterianas en ganado vacuno. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |